| NANOFORM FINLAND OYJ |
| Finnland |
| Gesundheit |
| FI4000330972 / A2P5N7 |
| 4YL (Frankfurt) |
| FRA:4YL, ETR:4YL, 4YL:GR |
| - |
| https://nanoform.com/ |
|
Nanoform Finland Plc is a biotechnology company that specializes in innovative drug delivery solutions. Its primary function is to enhance the bioavailability and efficacy of pharmaceutical compounds through its proprietary nanoparticle technology. T..
>Volltext.. |
| 36.91 Mio. EUR |
| 19.12 Mio. EUR |
| 3.61 Mio. EUR |
| -19.03 Mio. EUR |
| -18.21 Mio. EUR |
| -0.21 EUR |
| 6.32 Mio. EUR |
| 24.42 Mio. EUR |
| -18.17 Mio. EUR |
| 3.91 |
| 27.67% |
| 23.6% |
| - |
| - |
| - |
| - |
| NANOFORM |
| 05.04.26 |
|